Nirvana Life Sciences Inc.
NIRV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.58% | 375.00% | 0.00% | -80.00% | 42.86% |
| Total Receivables | 0.00% | -11.68% | 0.74% | -0.73% | 0.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.67% | 0.00% | 0.71% | -10.83% | 4.67% |
|
|
|||||
| Total Current Assets | -5.67% | 0.00% | 0.71% | -10.83% | 4.67% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.67% | 0.00% | -89.96% | 794.90% | 4.67% |
|
|
|||||
| Total Accounts Payable | -22.37% | 125.74% | -25.68% | -18.42% | 2.20% |
| Total Accrued Expenses | -78.81% | 7.95% | 3.69% | 3.85% | 4.26% |
| Short-term Debt | 6.17% | 6.10% | 35.48% | 104.12% | 17.96% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 0.00% | 0.00% |
| Total Other Current Liabilities | -- | -- | -- | 0.00% | 0.00% |
| Total Current Liabilities | -63.83% | 18.83% | 1.31% | 3.19% | 4.24% |
|
|
|||||
| Total Current Liabilities | -63.83% | 18.83% | 1.31% | 3.19% | 4.24% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 6.17% | 6.10% | 35.48% | 104.12% | 17.96% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -85.44% | 8,233.33% | -- |
| Total Liabilities | -63.83% | 16.52% | -9.20% | 17.22% | 4.41% |
|
|
|||||
| Common Stock & APIC | 13.71% | 4.74% | -3.72% | -0.87% | -0.50% |
| Retained Earnings | 0.14% | -6.75% | 2.85% | 0.17% | -0.15% |
| Treasury Stock & Other | -0.17% | 7.58% | -6.07% | 1.60% | -0.49% |
| Total Common Equity | 64.81% | -16.90% | -3.53% | -3.07% | -4.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 64.81% | -16.90% | -3.53% | -3.07% | -4.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 10.00% | -2.56% | -5.41% | -2.78% |
| Total Equity | 64.60% | -16.77% | -3.54% | -3.08% | -4.42% |
|
|
|||||